INO logo

Inovio Pharmaceuticals (INO) Non Current Assets

Annual Non Current Assets

$17.84 M
-$15.45 M-46.42%

31 December 2023

INO Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Non Current Assets

$15.78 M
-$461.10 K-2.84%

30 September 2024

INO Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

INO Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-46.4%-13.9%
3 y3 years-74.0%-67.4%
5 y5 years-58.8%-70.1%

INO Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-74.0%at low-67.4%at low
5 y5 years-74.0%at low-77.0%at low
alltimeall time-74.0%+708.0%-77.0%+617.0%

Inovio Pharmaceuticals Non Current Assets History

DateAnnualQuarterly
Sept 2024
-
$15.78 M(-2.8%)
June 2024
-
$16.24 M(-6.9%)
Mar 2024
-
$17.43 M(-2.3%)
Dec 2023
$153.11 M(-51.4%)
$17.84 M(-2.7%)
Sept 2023
-
$18.33 M(-38.4%)
June 2023
-
$29.75 M(-9.0%)
Mar 2023
-
$32.69 M(-1.8%)
Dec 2022
$315.24 M(-29.7%)
$33.29 M(-20.3%)
Sept 2022
-
$41.76 M(-3.4%)
June 2022
-
$43.21 M(-5.2%)
Mar 2022
-
$45.60 M(-4.0%)
Dec 2021
$448.44 M(-4.8%)
$47.50 M(-1.8%)
Sept 2021
-
$48.37 M(-2.1%)
June 2021
-
$49.42 M(-25.6%)
Mar 2021
-
$66.43 M(-3.2%)
Dec 2020
$471.17 M(+400.2%)
$68.60 M(+12.9%)
Sept 2020
-
$60.75 M(-0.6%)
June 2020
-
$61.12 M(-3.6%)
Mar 2020
-
$63.38 M(+27.4%)
Dec 2019
$94.20 M(+7.3%)
$49.75 M(-5.6%)
Sept 2019
-
$52.72 M(-3.4%)
June 2019
-
$54.56 M(-3.0%)
Mar 2019
-
$56.26 M(+29.9%)
Dec 2018
$87.81 M(-36.5%)
$43.30 M(-8.1%)
Sept 2018
-
$47.09 M(+0.0%)
June 2018
-
$47.08 M(-5.5%)
Mar 2018
-
$49.83 M(+1.9%)
Dec 2017
$138.36 M(+11.0%)
$48.88 M(-0.4%)
Sept 2017
-
$49.09 M(-5.5%)
June 2017
-
$51.98 M(+11.7%)
Mar 2017
-
$46.53 M(-5.2%)
Dec 2016
$124.60 M(-27.5%)
$49.11 M(-9.6%)
Sept 2016
-
$54.32 M(-3.0%)
June 2016
-
$56.02 M(+10.5%)
Mar 2016
-
$50.69 M(+20.7%)
Dec 2015
$171.85 M(+73.7%)
$41.99 M(-10.1%)
Sept 2015
-
$46.70 M(+18.0%)
June 2015
-
$39.56 M(+29.6%)
Mar 2015
-
$30.53 M(-7.0%)
Dec 2014
$98.95 M(+68.6%)
$32.84 M(+9.8%)
Sept 2014
-
$29.90 M(+2.4%)
June 2014
-
$29.21 M(-2.6%)
Mar 2014
-
$29.97 M(+1.2%)
Dec 2013
$58.68 M(+267.5%)
$29.60 M(-1.8%)
Sept 2013
-
$30.16 M(+18.5%)
June 2013
-
$25.46 M(-8.7%)
Mar 2013
-
$27.89 M(-4.4%)
Dec 2012
$15.97 M(-50.0%)
$29.17 M(+5.9%)
Sept 2012
-
$27.54 M(+1.0%)
June 2012
-
$27.28 M(-4.0%)
Mar 2012
-
$28.41 M(-2.7%)
Dec 2011
$31.91 M
$29.20 M(-4.4%)
DateAnnualQuarterly
Sept 2011
-
$30.53 M(+4.4%)
June 2011
-
$29.25 M(-9.6%)
Mar 2011
-
$32.37 M(-2.5%)
Dec 2010
$22.88 M(-48.7%)
$33.19 M(-5.3%)
Sept 2010
-
$35.04 M(+6.3%)
June 2010
-
$32.96 M(-9.9%)
Mar 2010
-
$36.60 M(+1.5%)
Dec 2009
$44.57 M(+192.0%)
$36.06 M(-14.2%)
Sept 2009
-
$42.01 M(+7.7%)
June 2009
-
$39.02 M(+65.6%)
Mar 2009
-
$23.56 M(-0.7%)
Dec 2008
$15.26 M(-47.4%)
$23.72 M(+5.1%)
Sept 2008
-
$22.58 M(-2.0%)
June 2008
-
$23.04 M(-1.3%)
Mar 2008
-
$23.35 M(+116.8%)
Dec 2007
$29.00 M(+18.5%)
$10.77 M(-4.2%)
Sept 2007
-
$11.24 M(-1.1%)
June 2007
-
$11.37 M(-1.1%)
Mar 2007
-
$11.49 M(+0.1%)
Dec 2006
$24.47 M(+33.6%)
$11.48 M(+6.3%)
Sept 2006
-
$10.80 M(-0.8%)
June 2006
-
$10.89 M(+1.9%)
Mar 2006
-
$10.69 M(+0.3%)
Dec 2005
$18.32 M(-0.6%)
$10.66 M(+9.6%)
Sept 2005
-
$9.73 M(-1.0%)
June 2005
-
$9.82 M(-0.7%)
Mar 2005
-
$9.89 M(+293.7%)
Dec 2004
$18.44 M(+34.1%)
$2.51 M(+3.7%)
Sept 2004
-
$2.42 M(-0.6%)
June 2004
-
$2.44 M(-1.2%)
Mar 2004
-
$2.47 M(-0.4%)
Dec 2003
$13.75 M(+409.7%)
$2.48 M(-1.5%)
Sept 2003
-
$2.51 M(-1.8%)
June 2003
-
$2.56 M(-2.3%)
Mar 2003
-
$2.62 M(-3.7%)
Dec 2002
$2.70 M(-25.2%)
$2.72 M(+0.1%)
Sept 2002
-
$2.72 M(-1.7%)
June 2002
-
$2.77 M(-6.6%)
Mar 2002
-
$2.96 M(-7.3%)
Dec 2001
$3.61 M(-56.3%)
-
Sept 2001
-
$3.20 M(+1.9%)
June 2001
-
$3.14 M(-3.1%)
Mar 2001
-
$3.24 M(-3.7%)
Mar 2001
$8.25 M(-29.0%)
-
Dec 2000
-
$3.36 M(+13.6%)
Sept 2000
-
$2.96 M(+22.3%)
June 2000
-
$2.42 M(+1.0%)
Mar 2000
$11.61 M(+52.8%)
$2.40 M(+4.3%)
Dec 1999
-
$2.30 M(+4.5%)
Sept 1999
-
$2.20 M(-4.3%)
June 1999
-
$2.30 M(+4.2%)
Mar 1999
$7.60 M
$2.21 M(+0.3%)
Dec 1998
-
$2.20 M

FAQ

  • What is Inovio Pharmaceuticals annual long term assets?
  • What is the all time high annual non current assets for Inovio Pharmaceuticals?
  • What is Inovio Pharmaceuticals annual non current assets year-on-year change?
  • What is Inovio Pharmaceuticals quarterly long term assets?
  • What is the all time high quarterly non current assets for Inovio Pharmaceuticals?
  • What is Inovio Pharmaceuticals quarterly non current assets year-on-year change?

What is Inovio Pharmaceuticals annual long term assets?

The current annual non current assets of INO is $17.84 M

What is the all time high annual non current assets for Inovio Pharmaceuticals?

Inovio Pharmaceuticals all-time high annual long term assets is $68.60 M

What is Inovio Pharmaceuticals annual non current assets year-on-year change?

Over the past year, INO annual long term assets has changed by -$15.45 M (-46.42%)

What is Inovio Pharmaceuticals quarterly long term assets?

The current quarterly non current assets of INO is $15.78 M

What is the all time high quarterly non current assets for Inovio Pharmaceuticals?

Inovio Pharmaceuticals all-time high quarterly long term assets is $68.60 M

What is Inovio Pharmaceuticals quarterly non current assets year-on-year change?

Over the past year, INO quarterly long term assets has changed by -$2.55 M (-13.94%)